Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Incidence and risk factors for agranulocytosis in Latin American countries-the Latin Study (2008)

  • Authors:
  • USP affiliated authors: ELUF NETO, JOSE - FM ; FALCÃO, ROBERTO PASSETTO - FMRP
  • USP Schools: FM; FMRP
  • DOI: 10.1007/s00228-008-0513-7
  • Subjects: DOENÇAS HEMATOLÓGICAS (EPIDEMIOLOGIA); FATORES DE RISCO; GRANULÓCITOS (PATOLOGIA); AMÉRICA LATINA
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s00228-008-0513-7 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: European Journal of Clinical Pharmacology

    ISSN: 0031-6970

    Citescore - 2017: 2.69

    SJR - 2017: 1.159

    SNIP - 2017: 1.277


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM10700092483-SFM BCSEP 101 2008
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      HAMERSCHLAK, Nelson; MALUF, Eliane; CAVALCANTI, Alexandre Biasi; et al. Incidence and risk factors for agranulocytosis in Latin American countries-the Latin Study. European Journal of Clinical Pharmacology, Berlin, v. 64, n. 9, p. 921-929, 2008. Disponível em: < http://www.springerlink.com/content/60421632u23357r3/fulltext.pdf" atrget="_blank > DOI: 10.1007/s00228-008-0513-7.
    • APA

      Hamerschlak, N., Maluf, E., Cavalcanti, A. B., Avezun Júnior, Á., Eluf-Neto, J., Falcão, R. P., et al. (2008). Incidence and risk factors for agranulocytosis in Latin American countries-the Latin Study. European Journal of Clinical Pharmacology, 64( 9), 921-929. doi:10.1007/s00228-008-0513-7
    • NLM

      Hamerschlak N, Maluf E, Cavalcanti AB, Avezun Júnior Á, Eluf-Neto J, Falcão RP, Lorand-Metze IG, Goldenberg D, Santana CL, Rodrigues D de OW, Passos LN da M, Coelho EO de M, Pintão MCT, Souza HM de, Borbolla JR, Pasquini R. Incidence and risk factors for agranulocytosis in Latin American countries-the Latin Study [Internet]. European Journal of Clinical Pharmacology. 2008 ; 64( 9): 921-929.Available from: http://www.springerlink.com/content/60421632u23357r3/fulltext.pdf" atrget="_blank
    • Vancouver

      Hamerschlak N, Maluf E, Cavalcanti AB, Avezun Júnior Á, Eluf-Neto J, Falcão RP, Lorand-Metze IG, Goldenberg D, Santana CL, Rodrigues D de OW, Passos LN da M, Coelho EO de M, Pintão MCT, Souza HM de, Borbolla JR, Pasquini R. Incidence and risk factors for agranulocytosis in Latin American countries-the Latin Study [Internet]. European Journal of Clinical Pharmacology. 2008 ; 64( 9): 921-929.Available from: http://www.springerlink.com/content/60421632u23357r3/fulltext.pdf" atrget="_blank

    Referências citadas na obra
    Ibáñez L, Vidal X, Ballarín E, Laporte JR (2005) Population-based drug-induced agranulocytosis. Arch Intern Med 165(8):869–874
    Young NS (1994) Agranulocytosis. JAMA 271(12):935–938
    Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study. JAMA 256(13):1749–1757
    Hamerschlak N, Cavalcanti AB (2005) Neutropenia, agranulocytosis and dipyrone. Sao Paulo Med J 123(5):247–249
    Kaufman DW, Kelly JP, Jurgelon JM et al (1996) Drugs in the aetiology of agranulocytosis and aplastic anaemia. Eur J Haematol Suppl 60:23–30
    Kaufman DW, Kelly JP, Levy M, Shapiro S (1991) The drug etiology of agranulocytosis and aplastic anemia: the international agranulocytosis and aplastic anemia study. New York, Oxford University Press
    Andersohn F, Konzen C, Garbe E (2007) Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med 146(9):657–665
    Ibáñez L, Vidal X, Ballarín E, Laporte JR (2005) Agranulocytosis associated with dipyrone (metamizol). Eur J Clin Pharmacol 60(11):821–829
    Shapiro S, Issaragrisil S, Kaufman DW et al (1999) Agranulocytosis in Bangkok, Thailand: a predominantly drug-induced disease with an unusually low incidence. Aplastic Anemia Study Group. Am J Trop Med Hyg 60(4):573–577
    Hamerschlak N, Montezuma MP, Bacal N et al (1993) Retrospective prevalence and incidence of drug-induced agranulocytosis in the city of São Paulo-Brazil. Rev Paul Med 111(1):294–298
    Hamerschlak N, Maluf E, Pasquini R et al (2005) Incidence of aplastic anemia and agranulocytosis in Latin America–the LATIN study. Sao Paulo Med J 123(3):101–104
    Hennekens CH, Buring JE (1987) Measures of disease frequency. In: Hennekens CH, Buring E (eds) Epidemiology in medicine. Lippincott, Williams & Wilkins, Philadelphia
    Hine LK, Gerstman BB, Wise RP, Tsong Y (1990) Mortality resulting from blood dyscrasias in the United States, 1984. Am J Med 88(2):151–153
    Böttiger LE, Furhoff AK, Holmberg L (1979) Drug-induced blood dyscrasias. A ten-year material from the Swedish Adverse Drug Reaction Committee. Acta Med Scand 205(6):457–461
    Arneborn P, Palmblad J (1979) Drug-induced neutropenias in the Stockholm region 1976–1977. Acta Med Scand 206(4):241–243
    Arneborn P, Palmblad J (1982) Drug-induced neutropenia–a survey for Stockholm 1973–1978. Acta Med Scand 212(5):289–292
    Tavassoli N, Duchayne E, Sadaba B et al (2007) Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals. Eur J Clin Pharmacol 63(3):221–228
    Andrès E, Zimmer J, Affenberger S et al (2006) Idiosyncratic drug-induced agranulocytosis: Update of an old disorder. Eur J Intern Med 17(8):529–535
    Benseñor IM (2005) Dipyrone and blood dyscrasia revisited: “non-evidence based medicine”. Sao Paulo Med J 123(3):99–100
    Garcia S, Canionero M, Lopes G (2006) Dipyrone-induced granulocytopenia: a case for awareness. Pharmacotherapy 26(3):440–442
    Hedenmalm K, Spigset O (2002) Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole). Eur J Clin Pharmacol 58(4):265–274
    Carvalho-Silva DR, Santos FR, Rocha J, Pena SD (2001) The phylogeography of Brazilian Y-chromosome lineages. Am J Hum Genet 68(1):281–286
    Dettling M, Cascorbi I, Opgen-Rhein C, Schaub R (2007) Clozapine-induced agranulocytosis in schizophrenic Caucasians: confirming clues for associations with human leukocyte class I and II antigens. Pharmacogenomics J 7(5):325–332
    Güzelcan Y, Scholte WF (2006) Door clozapine geïnduceerde agranulocytose: genetische en immunologische verklaringen. [Clozapine-induced agranulocytosis: genetic risk factors and an immunologic explanatory model]. Tijdschr Psychiatr 48(4):295–302
    World Health Organization (2006) WHO Statistical Information System (WHOSIS). Core Health Indicators. World Health Organization. http://www.who.int/whosis/database/core/core_select.cfm . Accessed 15 Feb 2007